GRHL3 Promotes Tumor Growth and Metastasis via the MEK Pathway in Colorectal Cancer

Table 1

Correlation analysis of GRHL3 expression and clinical characteristics of patients with CRC.

Feature		GRHL3
		Low or no expression	High expression
Gender
Male	63	24	39	0.324	0.569
Female	37	12	25
Age (years)
≤60	40	16	24	0.463	0.496
>60	60	20	40
Tumor size (cm)
<5	50	23	27	4.340	0.037
≥5	50	13	37
Differentiation
Well	29	11	18	0.113	0.945
Middle	55	19	36
Poor	16	6	10
TNM stage
I	15	7	8	9.603	0.022
II	34	18	16
III	38	8	30
IV	13	3	10
T stage
T1+2	26	14	12	4.857	0.028
T3+4	74	22	52
N stage
N0	53	26	27	8.490	0.014
N1	31	6	25
N2	16	4	12
M stage
M0	87	33	54	0.534	0.465
M1	13	3	10